logo
Plus   Neg
Share
Email

Infosys Q1 Profit Increases, Lifts FY Revenue Growth View; Stock Up

Infosys Limited (INFY) reported that its profit attributable to owners of the company for the first-quarter increased to $546 million or $0.13 per share from $534 million or $0.12 per share in the same quarter last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.13 per share for the quarter. Analysts' estimates typically exclude special items.

In Friday pre-Market trade, INFY is trading at $11.09, up $0.38 or 3.55 percent.

"Continuing our objective of improving shareholder returns, we have revised our capital allocation policy upwards to distribute ~ 85% of free cash flows cumulatively over a 5-year period," said Nilanjan Roy, CFO.

Quarterly revenues grew to $3.13 billion from $2.83 billion in the prior year. Analysts expected revenue of $3.08 billion for the quarter.

The company raised its fiscal year 2020 revenue growth guidance to a range of 8.5 percent - 10 percent in constant currency from the estimation of 7.5 percent - 9.5 percent growth.

The company said its current policy is to pay up to 70% of the free cash flow annually by way of dividend and/or buyback. The Board has approved a revised Capital Allocation Policy of the company after taking into consideration the strategic and operational cash requirements.

Effective from Financial year 2020, the company expects to return about 85% of the free cash flow cumulatively over a 5-year period through a combination of semi-annual dividends and/or share buyback and/or special dividends.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT